Next-generation bioprocessing
The biologics manufacturing landscape is undergoing a transformative shift as next-generation bioprocessing technologies deliver new levels of efficiency, scalability, and sustainability. Driven by growing global demand for monoclonal antibodies, vaccines, and advanced therapies, the industry is embracing innovations that streamline production while maintaining the highest standards of quality.
From the integration of Bioprocessing 4.0 tools to the implementation of smart, connected systems, these advancements are redefining how critical quality attributes are monitored and how production costs are controlled.
This dedicated feature explores the technologies, strategies, and digital innovations shaping the future of biologics manufacturing. Dive into expert perspectives, latest news, and curated resources designed to support informed decision-making and accelerate progress across the bioprocessing value chain.
New Gyrolab kits target HEK293 HCP detection
Developed with antibodies from BioGenes GmbH, the new kits enable rapid detection of HCPs from HEK293 cell lines, adding to Gyros Protein Technologies’ growing portfolio of ready-to-use host cell protein impurity kits.
Read release
Novel clarification technology addresses biologic manufacturing bottlenecks
Learn how Solventum’s scalable chromatographic clarification platform is helping to meet the growing demands of modern bioprocessing.
Read article
GMP-compliant cell sorting by flow cytometry
Jerry Barnhart and Marc-Aurele Brun of Sony Biotechnology discuss the role of flow cytometry in cell and gene therapy research, and how multiparametric approaches can address key challenges with rare population sorting.
Watch video
